AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2020
Jul 6, 2020
29745_dirs_2020-07-06_9351c1ce-72e4-4b49-8d40-ceb63b0fc111.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-07-05
Reporting Person: Pusey Leigh Ann (SVP, Corp. Affairs & Comm.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-05 | Common Stock | M | 2468 | — | Acquired | 5424 | Direct |
| 2020-07-05 | Common Stock | F | 1114 | $163.87 | Disposed | 4310 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-07-05 | Restricted Stock Unit | $ | M | 2468 | Disposed | Common Stock (2468.0) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
F2: The Restricted Stock Units vest in three installments: 2,394 on July 5, 2018; 2,394 on July 5, 2019; and 2,468 on July 5, 2020.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29